Losing weight is visible. You can see it in the mirror and feel it in how your clothes fit. Inflammation isn’t visible in the same way, but it’s just as relevant to whether you’re actually getting healthier, not just smaller.
If you’re on a GLP-1 medication, weight loss is probably the outcome you’re tracking most closely. But losing weight and reducing inflammation aren’t the same thing, and one doesn’t guarantee the other. Chronic, low-grade inflammation can persist regardless of what the scale says.
NOVOS Core and NOVOS Vital include ingredients studied for their role in inflammatory balance — a part of your health that a GLP-1 medication doesn’t directly address.
Quick Overview
- If you’re on a GLP-1 medication, weight loss doesn’t necessarily mean inflammation is improving, too. Chronic low-grade inflammation, sometimes called inflammaging, is one of the hallmarks of biological aging and doesn’t automatically track with body weight.
- In a randomized, placebo-controlled human trial, adults with type 2 diabetes taking 3.3g of trehalose daily for 12 weeks saw a significant reduction in CRP, a key marker of systemic inflammation.
- Additional research on trehalose is currently underway, looking at IL-6, TNF-alpha, and wound healing. Those results aren’t available yet, so they shouldn’t be treated as established findings.
- Fisetin, pterostilbene, and other NOVOS Core ingredients are studied for anti-inflammatory activity at the cellular and animal level.
- NOVOS Core and Vital are not designed to treat, reverse, or diagnose any inflammatory condition. They support inflammatory balance as one part of overall healthy aging.
Why Inflammation Matters Beyond the Scale
Losing weight can indeed improve several inflammation-linked conditions. Studies on GLP-1 medications specifically have found that weight loss on these drugs is tied to improved liver enzymes, lower inflammatory markers, and reduced cardiovascular risk factors, as well as better blood sugar control, with the effect growing alongside the amount of weight lost.”
But losing weight doesn’t automatically resolve inflammation on its own, and these improvements don’t cover the full picture. Chronic, low-grade inflammation, often called inflammaging, is one of the hallmarks of biological aging, and it can persist even as weight drops.
For someone on a GLP-1 medication, the medication’s job is weight loss assistance, not inflammatory balance. Those are two different biological processes, and progress on one doesn’t guarantee progress on the other.
What the Research Shows
Substantial evidence in this category comes from trehalose, an ingredient in NOVOS Vital. In a double-blind, randomized, placebo-controlled trial, adults with type 2 diabetes took 3.3g of trehalose daily for 12 weeks. C-reactive protein (CRP), a well-established marker of systemic inflammation, dropped significantly compared to placebo.
Separate research on trehalose is currently investigating IL-6, TNF-alpha, and wound-healing outcomes. That trial is still underway. Until it’s complete, those specific outcomes remain a research question, not a confirmed benefit.
NOVOS Vital’s zeaxanthin and lutein have a different evidence base. A 16-week trial using zeaxanthin-rich wolfberry found that higher zeaxanthin levels were associated with reduced oxidative stress in older adults. This is a separate mechanism from the trehalose CRP finding, and it speaks to oxidative stress specifically, not inflammatory markers.
NOVOS Core contributes ingredient-level evidence through fisetin, pterostilbene, glucosamine sulfate, ginger, and glycine. Fisetin in particular has been studied in cell and animal models for its ability to reduce inflammatory markers, including IL-6 and TNF-alpha, although this research hasn’t yet been replicated in the kind of large human trials that back the trehalose CRP finding.
Supporting Inflammatory Balance During Your GLP-1 Journey
Because a GLP-1 medication is built to address weight, not inflammation, supporting inflammatory balance comes down to a few separate habits that support a longevity routine:
- Follow a Mediterranean-style eating pattern: A 12-month randomized trial found that a Mediterranean diet enhanced with olive oil or nuts significantly reduced CRP and IL-6 compared to a low-fat diet.
- Protect your sleep: A meta-analysis of 72 studies found that sleep disturbance and shorter sleep duration were both associated with higher CRP and IL-6.
- Keep moving: Regular physical activity, even at moderate intensity, is one of the most consistent levers for lowering chronic inflammation.
- Stay hydrated, and keep protein intake up: Both matter more on a GLP-1 medication. Appetite suppression can make it easy to under-eat overall, affecting nutrition and hydration.
- Consider targeted nutrition: NOVOS Vital and NOVOS Core include ingredients studied for inflammatory balance, covered in more detail above.
See also: Chronic Inflammation and Aging: What To Know
What NOVOS Doesn’t Claim
NOVOS Core and Vital are not designed to treat, cure, or reverse any inflammatory condition, and they don’t replace medical evaluation for symptoms like persistent joint pain, swelling, or unexplained fatigue. The trehalose CRP data, while real, is a single marker that doesn’t capture the full picture of someone’s inflammatory status, and results vary by individual.
If you’re noticing symptoms that concern you, or if you have a diagnosed inflammatory condition, talk to your prescriber before adding any new supplement to your routine.
A steady daily foundation supports more than just the number on the scale. NOVOS Vital and Core address inflammatory balance in a way most GLP-1-focused products do not, while Bar and Boost round out nutrition and energy on the days you need them most.
FAQ About GLP-1 and Inflammation
Does losing weight on a GLP-1 medication reduce inflammation?
Not necessarily on its own. Weight loss and inflammatory balance are related but distinct processes, and lower body weight doesn’t guarantee lower inflammation.
What is inflammaging?
Inflammaging refers to the low-grade, chronic inflammation that tends to increase with age. It’s considered one of the hallmarks of biological aging and is linked to a range of age-related health concerns.
Can supplements lower CRP or inflammatory markers?
A human clinical trial found that 3.3g of daily trehalose reduced CRP over 12 weeks. Other ingredients have shown anti-inflammatory effects in cell and animal studies, although human data varies by ingredient.
What ingredients support healthy inflammation as you age?
Trehalose has the strongest human evidence to date, specifically for CRP reduction. Fisetin, pterostilbene, glucosamine sulfate, and zeaxanthin and lutein are also studied for roles in inflammatory balance.
Consult your healthcare provider before making changes to your medication, diet, or supplement routine.
